Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.52 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.52 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.52 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | AKT1 | P31749 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3412403 | 0.92 | RECQL (0.61) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL314324 | 0.92 | RECQL (0.61) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL314323 | 0.92 | RECQL (0.61) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL20272963 | 0.82 | ALDH1A1 (0.54) | ALDH1A1SRD5A2MAPTLMNAHPGD | |
| SCHEMBL28835815 | 0.81 | AKR1C3 (0.57) | ALDH1A1RECQLMAPTELANETDP1 | |
| SCHEMBL27947435 | 0.79 | TRPA1 (0.58) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL27947433 | 0.79 | TRPA1 (0.58) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL28588201 | 0.79 | MAPT (0.53) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL22572689 | 0.78 | RECQL (0.52) | ALDH1A1RECQLMAPTLMNACYP1B1 | |
| SCHEMBL22129150 | 0.78 | ELANE (0.66) | ALDH1A1SRD5A2NPC1ELANEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10927064-B2 | Process for the manufacturing of a compound comprising a (meth)acryloyl group | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-02-23 | — | — | US | disclosed |
| US-20200369590-A1 | PROCESS FOR THE MANUFACTURING OF A COMPOUND COMPRISING A (METH)ACRYLOYL GROUP | 3M INNOVATIVE PROPERTIES COMPANY | 2020-11-26 | — | — | US | disclosed |
| EP-3502090-B1 | PROCESS FOR THE MANUFACTURING OF A COMPOUND COMPRISING A (METH)ACRYLOYL GROUP | 3M INNOVATIVE PROPERTIES CO (US) | 2020-08-19 | — | — | EP | disclosed |
| EP-3502090-A1 | PROCESS FOR THE MANUFACTURING OF A COMPOUND COMPRISING A (METH)ACRYLOYL GROUP | 3M Innovative Properties Company (US) | 2019-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10927064-B2 | Process for the manufacturing of a compound comprising a (meth)acryloyl group | ADH5, ALKBH3, METTL3 | ALDH1A1 138/4885SRD5A2 3755/4885RECQL 3334/4885 |
| US-20200369590-A1 | PROCESS FOR THE MANUFACTURING OF A COMPOUND COMPRISING A (METH)ACRYLOYL GROUP | ADH5, ALKBH3, METTL3 | ALDH1A1 138/4885SRD5A2 3755/4885RECQL 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.